罕见-话题@MedSci

#罕见#

673篇内容 | 6901人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1467655, encodeId=b037146e6551d, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定, objectType=article, longId=724805, objectId=f9ffe2480599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ffe2480599, replyNumber=0, likeNumber=106, createdTime=2022-04-24, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ffe2480599, moduleTitle=博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ffe2480599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467654, encodeId=d7e9146e654c3, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=和我们一起助力中国罕见病科研事业 | 瑞鸥公益基金会2022年度招聘, objectType=article, longId=724344, objectId=aacce24344a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aacce24344a2, replyNumber=0, likeNumber=106, createdTime=2022-04-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aacce24344a2, moduleTitle=和我们一起助力中国罕见病科研事业 | 瑞鸥公益基金会2022年度招聘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aacce24344a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467653, encodeId=d060146e6531a, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=NICE推荐Vimizim用于罕见病-4A型粘多糖贮积症, objectType=article, longId=301612, objectId=50c830161298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c830161298, replyNumber=0, likeNumber=112, createdTime=2022-03-26, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c830161298, moduleTitle=NICE推荐Vimizim用于罕见病-4A型粘多糖贮积症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50c830161298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467652, encodeId=739f146e652fb, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=武田的Exkivity (mobocertinib) 获得英国MHRA有条件上市许可，用于治疗罕见非小细胞肺癌, objectType=article, longId=301596, objectId=a1cb301596e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1cb301596e2, replyNumber=0, likeNumber=83, createdTime=2022-03-26, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1cb301596e2, moduleTitle=武田的Exkivity (mobocertinib) 获得英国MHRA有条件上市许可，用于治疗罕见非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1cb301596e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467651, encodeId=c163146e65117, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=Br J Dermatol：泛发性脓疱型银屑病：罕见病和orphan病例, objectType=article, longId=301214, objectId=401030121413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=401030121413, replyNumber=0, likeNumber=75, createdTime=2022-03-21, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=401030121413, moduleTitle=Br J Dermatol：泛发性脓疱型银屑病：罕见病和orphan病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=401030121413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467650, encodeId=5e83146e65021, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=Oncologist：全球多中心真实世界探索EGFR-TKIs治疗罕见EGFR突变NSCLC患者的疗效, objectType=article, longId=300760, objectId=f451300e604a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f451300e604a, replyNumber=0, likeNumber=76, createdTime=2022-03-16, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f451300e604a, moduleTitle=Oncologist：全球多中心真实世界探索EGFR-TKIs治疗罕见EGFR突变NSCLC患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f451300e604a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467649, encodeId=6651146e649c0, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=加拿大亿万富翁Chip Wilson宣布投资1亿美元用于罕见病FSHD研究, objectType=article, longId=300503, objectId=3caa30050314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3caa30050314, replyNumber=0, likeNumber=74, createdTime=2022-03-13, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3caa30050314, moduleTitle=加拿大亿万富翁Chip Wilson宣布投资1亿美元用于罕见病FSHD研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3caa30050314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467648, encodeId=e9d9146e6487b, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=2022年两会：哪些提案与医疗和医药有关？长护险、互联网医院、罕见病、数据银行, objectType=article, longId=300002, objectId=abc830000299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc830000299, replyNumber=0, likeNumber=85, createdTime=2022-03-05, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc830000299, moduleTitle=2022年两会：哪些提案与医疗和医药有关？长护险、互联网医院、罕见病、数据银行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc830000299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467647, encodeId=6a06146e64794, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=瑞鸥公益基金会创立，梅斯医学任理事单位，助力罕见病科研与转化医学创新, objectType=article, longId=724718, objectId=d173e247184c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d173e247184c, replyNumber=0, likeNumber=115, createdTime=2022-03-02, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d173e247184c, moduleTitle=瑞鸥公益基金会创立，梅斯医学任理事单位，助力罕见病科研与转化医学创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d173e247184c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467646, encodeId=23bf146e64620, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=【直播预告】共画罕见病很大同心圆 | 国际罕见病日, objectType=article, longId=299794, objectId=d57d299e946c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d57d299e946c, replyNumber=0, likeNumber=96, createdTime=2022-03-02, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d57d299e946c, moduleTitle=【直播预告】共画罕见病很大同心圆 | 国际罕见病日, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d57d299e946c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467673, encodeId=51a9146e67311, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=摄入蛋白质后，出现呕吐、腹泻、昏迷、无力……全球报道仅200例的罕见病终确诊, objectType=article, longId=299421, objectId=e66c29942149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66c29942149, replyNumber=0, likeNumber=69, createdTime=2022-02-24, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66c29942149, moduleTitle=摄入蛋白质后，出现呕吐、腹泻、昏迷、无力……全球报道仅200例的罕见病终确诊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66c29942149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467645, encodeId=787c146e6452c, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=JEADV：二期梅毒中罕见的神经性和耳梅毒1例, objectType=article, longId=294911, objectId=9f462949111e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f462949111e, replyNumber=0, likeNumber=96, createdTime=2022-01-31, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f462949111e, moduleTitle=JEADV：二期梅毒中罕见的神经性和耳梅毒1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f462949111e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467644, encodeId=5b63146e64494, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=Movement Disorder：复旦·华山医院，PET成像揭示罕见额颞叶痴呆疾病进展, objectType=article, longId=294041, objectId=bceb2940412b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bceb2940412b, replyNumber=0, likeNumber=92, createdTime=2022-01-17, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bceb2940412b, moduleTitle=Movement Disorder：复旦·华山医院，PET成像揭示罕见额颞叶痴呆疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bceb2940412b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467643, encodeId=7c56146e64389, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=SMC 批准针对罕见突变晚期肠癌患者的免疫治疗组合（Nivolumab联合ipilmumab）, objectType=article, longId=292253, objectId=112d2922537c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=112d2922537c, replyNumber=0, likeNumber=80, createdTime=2021-12-21, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=112d2922537c, moduleTitle=SMC 批准针对罕见突变晚期肠癌患者的免疫治疗组合（Nivolumab联合ipilmumab）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=112d2922537c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467642, encodeId=d487146e6422b, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=一例罕见致病菌导致的感染性心内膜炎的诊疗过程, objectType=article, longId=265046, objectId=40d72650461a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40d72650461a, replyNumber=0, likeNumber=79, createdTime=2021-12-14, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40d72650461a, moduleTitle=一例罕见致病菌导致的感染性心内膜炎的诊疗过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40d72650461a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467641, encodeId=d3fd146e64132, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=Thorac Cancer：伴有罕见突变的晚期或转移性NSCLC患者的真实世界数据, objectType=article, longId=264988, objectId=11502649888a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11502649888a, replyNumber=0, likeNumber=71, createdTime=2021-12-13, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11502649888a, moduleTitle=Thorac Cancer：伴有罕见突变的晚期或转移性NSCLC患者的真实世界数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11502649888a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467640, encodeId=239a146e640a1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=儿童肿瘤很「罕见」，却离我们那么近又那么远, objectType=article, longId=221219, objectId=46692212192c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46692212192c, replyNumber=0, likeNumber=87, createdTime=2021-11-30, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46692212192c, moduleTitle=儿童肿瘤很「罕见」，却离我们那么近又那么远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46692212192c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467639, encodeId=15ea146e639bd, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=NEJM：这种10岁前就会死亡的罕见病，被慢病毒基因疗法修复了, objectType=article, longId=220959, objectId=e72c22095940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e72c22095940, replyNumber=0, likeNumber=91, createdTime=2021-11-26, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e72c22095940, moduleTitle=NEJM：这种10岁前就会死亡的罕见病，被慢病毒基因疗法修复了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e72c22095940)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467638, encodeId=8eb6146e638a1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=从常规血气到代谢再到基因检测，罕见病例快速、精准检验全过程, objectType=article, longId=220848, objectId=26f1220848d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26f1220848d3, replyNumber=0, likeNumber=79, createdTime=2021-11-24, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26f1220848d3, moduleTitle=从常规血气到代谢再到基因检测，罕见病例快速、精准检验全过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26f1220848d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1467636, encodeId=92c6146e63616, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, objectTitle=J Immunother Cancer：Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性：来自CA209-538临床研究, objectType=article, longId=220657, objectId=8c3622065e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c3622065e52, replyNumber=0, likeNumber=67, createdTime=2021-11-22, rootId=0, userName=syscxl, userId=29f36868190, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c3622065e52, moduleTitle=J Immunother Cancer：Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性：来自CA209-538临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c3622065e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

罕见

2020-05-29

柳叶一刀 (审核中...)

前往app查看评论内容

#罕见#

博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定

2022-04-24

柳叶一刀 (审核中...)

前往app查看评论内容

#罕见#

和我们一起助力中国罕见病科研事业 | 瑞鸥公益基金会2022年度招聘

2022-04-17

柳叶一刀 (审核中...)

前往app查看评论内容

#罕见#

NICE推荐Vimizim用于罕见病-4A型粘多糖贮积症

2022-03-26

柳叶一刀 (审核中...)

前往app查看评论内容

#罕见#

武田的Exkivity (mobocertinib) 获得英国MHRA有条件上市许可，用于治疗罕见非小细胞肺癌

2022-03-26

柳叶一刀 (审核中...)

前往app查看评论内容

#罕见#

Br J Dermatol：泛发性脓疱型银屑病：罕见病和orphan病例

2022-03-21

柳叶一刀 (审核中...)

前往app查看评论内容

#罕见#

Oncologist：全球多中心真实世界探索EGFR-TKIs治疗罕见EGFR突变NSCLC患者的疗效

2022-03-16

syscxl (审核中...)

前往app查看评论内容

#罕见#

加拿大亿万富翁Chip Wilson宣布投资1亿美元用于罕见病FSHD研究

2022-03-13

syscxl (审核中...)

前往app查看评论内容

#罕见#

2022年两会：哪些提案与医疗和医药有关？长护险、互联网医院、罕见病、数据银行

2022-03-05

syscxl (审核中...)

前往app查看评论内容

#罕见#

瑞鸥公益基金会创立，梅斯医学任理事单位，助力罕见病科研与转化医学创新

2022-03-02

syscxl (审核中...)

前往app查看评论内容

#罕见#

【直播预告】共画罕见病很大同心圆 | 国际罕见病日

2022-03-02

syscxl (审核中...)

前往app查看评论内容

#罕见#

摄入蛋白质后，出现呕吐、腹泻、昏迷、无力……全球报道仅200例的罕见病终确诊

2022-02-24

syscxl (审核中...)

前往app查看评论内容

#罕见#

JEADV：二期梅毒中罕见的神经性和耳梅毒1例

2022-01-31

syscxl (审核中...)

前往app查看评论内容

#罕见#

Movement Disorder：复旦·华山医院，PET成像揭示罕见额颞叶痴呆疾病进展

2022-01-17

syscxl (审核中...)

前往app查看评论内容

#罕见#

SMC 批准针对罕见突变晚期肠癌患者的免疫治疗组合（Nivolumab联合ipilmumab）

2021-12-21

syscxl (审核中...)

前往app查看评论内容

#罕见#

一例罕见致病菌导致的感染性心内膜炎的诊疗过程

2021-12-14

syscxl (审核中...)

前往app查看评论内容

#罕见#

Thorac Cancer：伴有罕见突变的晚期或转移性NSCLC患者的真实世界数据

2021-12-13

syscxl (审核中...)

前往app查看评论内容

#罕见#

儿童肿瘤很「罕见」，却离我们那么近又那么远

2021-11-30

syscxl (审核中...)

前往app查看评论内容

#罕见#

NEJM：这种10岁前就会死亡的罕见病，被慢病毒基因疗法修复了

2021-11-26

syscxl (审核中...)

前往app查看评论内容

#罕见#

从常规血气到代谢再到基因检测，罕见病例快速、精准检验全过程

2021-11-24

syscxl (审核中...)

前往app查看评论内容

#罕见#

J Immunother Cancer：Nivolumab 联合 ipilimumab治疗晚期罕见妇科肿瘤的疗效和安全性：来自CA209-538临床研究

2021-11-22

科室
- - 订阅+
  - 更多科室
工具
服务